Metatissue

Ilhavo, Portugal Founded: 2018 • Age: 8 yrs
Provider of human protein-based products for cell culture, tissue engineering, and disease modeling applications
Annual revenue - Latest available
Total funding - 3 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 2 Services tracked
Competitors 9 Brand Intelligence

About Metatissue

Metatissue is a company based in Ilhavo (Portugal) founded in 2018 by Joao F Mano and Catarina Custodio. Metatissue offers products and services including Hydrogels and hPLMA Unit. Metatissue operates in a competitive market with competitors including Multus, Nu-Tek Biosciences, Kohjin Bio, Sarvoshadhi Bio and metabolIQ, among others.

  • Headquarter Ilhavo, Portugal
  • Founders Joao F Mano, Catarina Custodio
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $79.77 K (USD), Grant

    Jun 01, 2022

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Metatissue

Metatissue offers a comprehensive portfolio of products and services, including Hydrogels and hPLMA Unit.

Product name locked
Category locked
Primary

Human protein-based gels for 3D cell culture and tissue regeneration.

Product name locked
Category locked
Locked

Lyophilized derivative for customizable hydrogels in research applications.

Funding Insights of Metatissue

Investors in Metatissue

Metatissue has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Premium access

Investor details for Metatissue

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Metatissue

Investments
Premium access

Investment portfolio details for Metatissue

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Metatissue

Premium access

Detailed financials for Metatissue

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Metatissue Comparisons

Metatissue Primary company
Description
Provider of human protein-based products for cell culture, t...
Location
Ilhavo, Portugal
Founded Year
2018
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Metatissue

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Metatissue

Metatissue operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Multus, Nu-Tek Biosciences, Kohjin Bio, Sarvoshadhi Bio and metabolIQ, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of lab-grown meat alternatives
Locked Locked Locked
Develops innovative animal-free peptones and cell culture media for pharmaceutical use.
Locked Locked Locked
Tissue culture media provided for regenerative medicine and immunotherapy research.
Locked Locked Locked
Customized cell culture media for biotechnology are developed.
Locked Locked Locked
Developer of cell culture medium for pharmaceutical screening and personalized medicine
Premium access

Detailed competitors of Metatissue

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Metatissue

Premium access

Complete news archive for Metatissue

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Metatissue

Metatissue was founded in 2018 and raised its 1st funding round 3 years after it was founded.

Metatissue is headquartered in Ilhavo, Portugal. It is registered at Ilhavo, Aveiro, Portugal.

Catarina Custodio is the current CEO of Metatissue. They have also founded this company.

Provider of human protein-based products for cell culture, tissue engineering, and disease modeling applications. The companys products chemically modified human-derived proteins to prepare hydrogels, sponges and bioinks that mimic the human environment, enabling researchers to develop in vitro models and reduce the need for animal testing.

Metatissue's top competitors include Multus, Onkologic and Cellular Engineering Technologies.

Metatissue offers Hydrogels and hPLMA Unit.

Metatissue has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available